Epigenetic Regulation in Kidney Diseases
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".
Deadline for manuscript submissions: closed (15 November 2021) | Viewed by 216
Special Issue Editor
Special Issue Information
Dear Colleagues,
Chronic kidney disease (CKD) has become a common disease because the number of patients with diabetic kidney disease or hypertension is increasing. An increasing number of patients with CKD receive doctor visits at regular intervals. However, new therapies or treatments have not been discovered for CKD. Novel drugs which target epigenetic mechanisms have not been developed in renal fields. We would like to review the epigenetic roles and new treatments that target epigenetic regulations in renal failure. We also seek to discuss epigenetic roles in the kidney in this section.
Dr. Imari Mimura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Tubulointerstitial fibrosis
- AKI to CKD
- Hypoxia
- Histone
- Demethylase
